Liver Cancer News & Features
The amount of alcohol a person has to drink to risk developing liver cancer has been narrowed down.
The risk of disease recurrence in liver cancer patients who have undergone a liver transplant can now be more accurately calculated, thanks to new tool.
An interventional x-ray guidance device approved by the U.S. Food and Drug Administration in 2013 may have the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy for liver cancer.
AlluraClarity, an FDA-approved X-ray guidance device, has the potential to reduce radiation exposure in patients with liver cancer.
Triclosan, a popular antimicrobial agent in soaps, detergents, and plastics, has been found to promote liver cancer in mice.
Liver Cancer Videos
Liver Cancer Clinical Trials
- Risk of thyroid cancer increases after a breast cancer diagnosis
- Childhood leukemia study reveals disease subtypes and new treatment options
- Counseling cancer patients on effective nutritional practices
- Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure
- Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
- Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)
- Joint statement offers new recommendations for treating cardiovascular conditions
- Physicians who review patients' meds more likely to achieve health goals
- Patients expect more information regarding radiation-related tests
- Prevalence of childhood cancer survivors increasing
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|